MXJVX
Price
$8.71
Change
-$0.19 (-2.13%)
Updated
Dec 18 closing price
VTISX
Price
$135.75
Change
-$2.83 (-2.04%)
Updated
Dec 18 closing price
Ad is loading...

MXJVX vs VTISX

Header iconMXJVX vs VTISX Comparison
Open Charts MXJVX vs VTISXBanner chart's image
Empower International Value Instl
Price$8.71
Change-$0.19 (-2.13%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Idx Instl Sel
Price$135.75
Change-$2.83 (-2.04%)
VolumeN/A
CapitalizationN/A
MXJVX vs VTISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MXJVX vs. VTISX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXJVX is a Sell and VTISX is a Buy.

FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 443B vs. MXJVX (1.23B). MXJVX pays higher dividends than VTISX: MXJVX (3.72) vs VTISX (3.32). MXJVX was incepted earlier than VTISX: MXJVX (10 years) vs VTISX (8 years). MXJVX is a more actively managed with annual turnover of: 18.00 vs. VTISX (4.00). MXJVX has a lower initial minimum investment than VTISX: MXJVX (0) vs VTISX (3000000000). VTISX annual gain was more profitable for investors over the last year : 8.85 vs. MXJVX (8.36). MXJVX return over 5 years is better than : 19.58 vs. VTISX (14.05).
MXJVXVTISXMXJVX / VTISX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years8 years-
Gain YTD8.0326.094132%
Front LoadN/AN/A-
Min. Initial Investment03000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B443B0%
Annual Yield % from dividends3.723.32112%
Returns for 1 year8.368.8594%
Returns for 3 years3.741.14328%
Returns for 5 years19.5814.05139%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCAP19.56-0.26
-1.31%
Crescent Capital BDC
RL227.93-3.73
-1.61%
Ralph Lauren Corp
CAKE50.39-0.97
-1.89%
Cheesecake Factory
APLT1.10-0.05
-4.35%
Applied Therapeutics
MBRX1.86-0.33
-15.07%
Moleculin Biotech